[传导系统节奏 (CSP) 对于每个患者? : CSP应该取代经典的右心室和双心室刺激吗?
Jörn Schmitt1, Sergio Richter2
1Abteilung für Kardiologie, Asklepios Klinik Langen, Röntgenstraße 20, 63225, Langen, Deutschland. jo.schmitt@asklepios.com.
Herz
|October 21, 2025
概括
与传统方法相比,导电系统节奏 (CSP) 提供了更生理性的心脏收缩. 虽然指导方针正在不断发展,但CSP,特别是His-bundle节奏,在可行的情况下优先于右心室节奏.
科学领域:
- 心脏病学 心脏病学
- 电子生理学 电子生理学
- 生物医学工程 生物医学工程
背景情况:
- 导电系统节奏 (CSP) 涉及刺激心脏的电路.
- 目前的节拍方法通常涉及右心室刺激,这可能导致异步收缩.
研究的目的:
- 为了评估直接的His-捆刺激的生理益处.
- 将CSP与传统的右心室节奏和心脏再同步治疗 (CRT) 进行比较.
主要方法:
- 直接刺激His捆,心脏导电系统的一个组成部分.
- 评估心电图参数和左心室收缩模式.
- 与右心室顶部节奏和CRT进行比较.
主要成果:
- 他的捆节奏提供了一个更均和同步的左心室收缩.
- CSP表现出稳定的电气参数和更简单的技术应用.
- 在等待CRT比较的情况下,CSP显示了对右心室垂节奏的偏好.
结论:
- 直接他的捆绑节奏代表了一个高度生理的节奏策略.
- 在收缩同步和电稳定性方面,CSP提供了优势.
- 需要进一步进行比较研究,以巩固CSP与CRT之间的作用.
相关概念视频
Conduction System of the Heart
12.5K
Autorhythmicity is a term that refers to the heart's inherent ability to generate electrical signals and instigate muscle contractions. This self-regulating conduction system within the heart consists of two key components: the pacemaker cells and specialized conducting cells.
The pacemaker cells are located in two primary nodes: the sinoatrial (SA) node and the atrioventricular (AV) node. The SA node pacemaker cells can autonomously depolarize, triggering an action potential that leads to the...
The pacemaker cells are located in two primary nodes: the sinoatrial (SA) node and the atrioventricular (AV) node. The SA node pacemaker cells can autonomously depolarize, triggering an action potential that leads to the...
12.5K
Conduction System of the Heart
3.4K
The cardiac conduction system produces and transmits electrical impulses that prompt myocardial contraction, ensuring efficient heart function. This intricate system ensures that the heart beats in a coordinated and efficient manner, beginning with the atria and then the ventricles. The conduction system optimizes cardiac output by maintaining this precise sequence, which is crucial for adequate blood circulation.
This system relies on the unique properties of nodal and Purkinje cells:...
This system relies on the unique properties of nodal and Purkinje cells:...
3.4K
Cardiomyopathy V: Interprofessional Care
335
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
335
Dysrhythmias VI: Management of Dysrhythmias
428
Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...
428
Electrophysiology of Normal Cardiac Rhythm
8.7K
The normal cardiac rhythm is a synchronized electrical activity that facilitates the regular and coordinated contraction of the heart muscle. This process is essential for efficient blood circulation throughout the body. The fundamental elements involved in establishing and maintaining this rhythm include the unique electrical properties of cardiac muscle cells, the sinoatrial (SA) node's pacemaker function, the specialized conducting system, and the ionic mechanisms underlying each phase...
8.7K
Cardiomyopathy II: Dilated Cardiomyopathy
464
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
464


